Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use EMFLAZA® safely and effectively. See full prescribing information for EMFLAZA. EMFLAZA® (deflazacort) tablets, for oral use EMFLAZA® (deflazacort) oral suspension Initial U.S. Approval: 2017
Medication labelWhy this: Advisory · dailymed-prescription
EMFLAZA is indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients 2 years of age and older.
- generic_name
- deflazacort
- product_names
- deflazacort
- ndc
- 52856-501, 52856-501-01, 52856-502, 52856-502-03, 52856-503, 52856-503-03, 52856-504, 52856-504-03, 52856-505, 52856-505-22
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en